ADMA Biologics, Inc. Class Action Lawsuit
Company: ADMA Biologics, Inc.
Ticker: (NASDAQ) ADMA
Class Action Period: August 9, 2024 - March 25, 2026
See If You Qualify For Monetary Reward
Join the ADMA Biologics, Inc. Class Action Lawsuit
CLASS ACTION PERIOD
August 9, 2024 - March 25, 2026
Allegations
The complaint filed against ADMA Biologics, Inc. alleges the company made statements that were materially false and/or misleading and/or failed to disclose that: (1) ADMA Biologics engaged in an undisclosed related party transaction; (2) ADMA Biologics used channel stuffing to create an appearance of revenue; (3) ADMA Biologics lacked adequate internal controls; (4) as a result, defendants’ statements about ADMA Biologics’ business, operations, and prospects were materially false and misleading and/or lacked a reasonable basis at all relevant times.
Eligibility
To join the lawsuit, you must have experienced a loss on ADMA Biologics, Inc. shares purchased within the class period specified above.
Lead Plaintiff Deadline
If you suffered a loss in ADMA Biologics, Inc. during the relevant time frame or pursuant to the relevant offering(s), you have until August 10, 2026 to request that the Court appoint you as lead plaintiff. Your ability to share in any recovery doesn't require that you serve as a lead plaintiff.
Frequently Asked Questions
- How do I join the lawsuit against ADMA Biologics, Inc. (NASDAQ: ADMA)?
Investors who purchased shares of ADMA Biologics, Inc. (NASDAQ: ADMA) during the class period (August 9, 2024 - March 25, 2026) can join by submitting their transaction details through this case page.
- Ensure your purchase falls within the class period
- Provide basic transaction and loss details
- Submit your information before the deadline
The lead plaintiff deadline for this case is August 10, 2026, so investors should act quickly to protect their rights.
- Who is eligible for the ADMA Biologics, Inc. lawsuit?
Anyone who bought shares of ADMA Biologics, Inc. (NASDAQ: ADMA) during August 9, 2024 - March 25, 2026 and suffered financial losses may qualify.
- What is the lead plaintiff deadline to join the ADMA Biologics, Inc. case?
The lead plaintiff deadline for the ADMA Biologics, Inc. lawsuit is August 10, 2026. Investors should act quickly to avoid missing this deadline.
- What is the class period for ADMA Biologics, Inc.?
The class period for ADMA Biologics, Inc. (NASDAQ: ADMA) is August 9, 2024 - March 25, 2026, during which investors may have been affected by alleged misconduct.
- Can I still join the ADMA Biologics, Inc. lawsuit if I sold my shares?
Yes. Investors who purchased ADMA Biologics, Inc. shares during August 9, 2024 - March 25, 2026 may still qualify, even if they sold their shares later.
- How much compensation can I receive from the ADMA Biologics, Inc. lawsuit?
Compensation depends on the total losses and the final settlement. Eligible investors in the ADMA Biologics, Inc. case may receive a portion of the recovery.
- Do I need to pay to participate in the ADMA Biologics, Inc. case?
No, most securities fraud cases involving ADMA Biologics, Inc. operate on a contingency basis, meaning there are no upfront costs unless there is a recovery.
- Will I need to appear in court for the ADMA Biologics, Inc. lawsuit?
In most cases, investors do not need to appear in court. The legal team manages the ADMA Biologics, Inc. case on behalf of participants.
- What documents are required for the ADMA Biologics, Inc. lawsuit?
To participate in the ADMA Biologics, Inc. lawsuit, investors may need to provide transaction records, purchase dates, number of shares, and loss details.
- What happens after I submit my trade information for ADMA Biologics, Inc.?
After submission, your details for the ADMA Biologics, Inc. case will be reviewed, and you may be contacted regarding eligibility or next steps.
- Is this legal advice for the ADMA Biologics, Inc. lawsuit?
No, this page provides information about the ADMA Biologics, Inc. case and does not constitute legal advice or create an attorney-client relationship.
- Why should I act quickly on the ADMA Biologics, Inc. case?
The lead plaintiff deadline for the ADMA Biologics, Inc. lawsuit is August 10, 2026. If you are an investor, you may have the opportunity to seek appointment as lead plaintiff or remain an absent class member.
EXPLORE MORE CASES
FS KKR Capital Corp
FSK
FS KKR Capital Corp. (FSK) Securities Class Action Lawsuit Update
Lead Plaintiff Deadline: July 6, 2026
Class Period: May 8, 2024 - February 25, 2026
Graphic Packaging Holding Company
GPK
Graphic Packaging Holding Company (GPK) Securities Class Action Lawsuit Update
Lead Plaintiff Deadline: July 6, 2026
Class Period: February 4, 2025 - February 2, 2026